Document is current
Any future updates will be listed below
-
Authors
Van Nerom, Katleen
Ainelo, Andres https://orcid.org/0000-0003-4073-3359
Coppieters ‘t Wallant, Kyo https://orcid.org/0000-0003-2358-999X
Talavera-Perez, Ariel https://orcid.org/0000-0002-1865-5959
Echemendia-Blanco, Dannele
Peeters, Sarah
El Khalfaoui Oulali, Brahim
Tamman, Hedvig https://orcid.org/0000-0003-4453-7814
Kurata, Tatsuaki
Roghanian, Mohammad https://orcid.org/0000-0003-3116-3817
Martens, Chloé https://orcid.org/0000-0002-1617-4238
Pardon, Els https://orcid.org/0000-0002-2466-0172
Steyaert, Jan https://orcid.org/0000-0002-3825-874X
Hauryliuk, Vasili https://orcid.org/0000-0003-2389-5057
Garcia-Pino, Abel https://orcid.org/0000-0002-0634-0300
- License Information
-
More Information
Article History
Received: 28 August 2025
Accepted: 1 May 2026
First Online: 13 May 2026
Competing interests
: A.G.-P. is co-founder and stockholder of Santero Therapeutics; the other authors declare no competing interests.
